These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25775760)

  • 1. [The effect and the analysis of the influence factors of sublingual immunotherapy on patients with pharyngitis and allergy to house dust mite].
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Oct; 28(19):1511-3. PubMed ID: 25775760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
    Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.
    de Bot CM; Moed H; Berger MY; Röder E; Hop WC; de Groot H; de Jongste JC; van Wijk RG; Bindels PJ; van der Wouden JC
    Pediatr Allergy Immunol; 2012 Mar; 23(2):150-8. PubMed ID: 22017365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.
    Kiatiwat P; Sangasapaviliya A; Pradubpongsa P; Sangkanjanavanich S; Chiewchalermsri C; Jacquet A; Jaisupa N; Jindarat S; Boonpiyathad T; Mitthamsiri W
    Allergy; 2023 Jul; 78(7):2019-2021. PubMed ID: 36754574
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW; Virchow JC; Zieglmayer P; Ljørring C; Smith IM; Mosbech H
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?
    Kiykim A; Mumcu G; Ogulur I; Karakoc-Aydiner E; Direskeneli H; Baris S; Cagan H; Ozen A
    Int Arch Allergy Immunol; 2017; 174(1):52-56. PubMed ID: 28950285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy.
    Bisyuk Y; DuBuske I; DuBuske LM
    Allergy Asthma Proc; 2021 Jan; 42(1):36-42. PubMed ID: 33404387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term efficacy of sublingual immunotherapy in different courses for house dust mite-induced allergic rhinitis.
    Yang J; Zheng J; Zhou Y; Qiu Q; Zhan J; Wei X
    Am J Otolaryngol; 2024; 45(2):104118. PubMed ID: 38041893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.
    Tourdot S; Airouche S; Berjont N; Da Silveira A; Mascarell L; Jacquet A; Caplier L; Langelot M; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2011 Dec; 41(12):1784-92. PubMed ID: 22092967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.